244 related articles for article (PubMed ID: 31653969)
21. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
[TBL] [Abstract][Full Text] [Related]
22. The mechanosensitive TRPV2 calcium channel promotes human melanoma invasiveness and metastatic potential.
Shoji KF; Bayet E; Leverrier-Penna S; Le Devedec D; Mallavialle A; Marionneau-Lambot S; Rambow F; Perret R; Joussaume A; Viel R; Fautrel A; Khammari A; Constantin B; Tartare-Deckert S; Penna A
EMBO Rep; 2023 Apr; 24(4):e55069. PubMed ID: 36744297
[TBL] [Abstract][Full Text] [Related]
23. TRPV2 mediates adrenomedullin stimulation of prostate and urothelial cancer cell adhesion, migration and invasion.
Oulidi A; Bokhobza A; Gkika D; Vanden Abeele F; Lehen'kyi V; Ouafik L; Mauroy B; Prevarskaya N
PLoS One; 2013; 8(5):e64885. PubMed ID: 23741410
[TBL] [Abstract][Full Text] [Related]
24. A TRPV2 interactome-based signature for prognosis in glioblastoma patients.
Doñate-Macián P; Gómez A; Dégano IR; Perálvarez-Marín A
Oncotarget; 2018 Apr; 9(26):18400-18409. PubMed ID: 29719613
[TBL] [Abstract][Full Text] [Related]
25. Amelioration of diabetes-induced cognitive impairment by Transient Receptor Potential Vanilloid 2 (TRPV2) channel inhibitor: Behavioral and mechanistic study.
Thapak P; Bishnoi M; Sharma SS
Neurochem Int; 2020 Oct; 139():104783. PubMed ID: 32652268
[TBL] [Abstract][Full Text] [Related]
26. The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
Morelli MB; Offidani M; Alesiani F; Discepoli G; Liberati S; Olivieri A; Santoni M; Santoni G; Leoni P; Nabissi M
Int J Cancer; 2014 Jun; 134(11):2534-46. PubMed ID: 24293211
[TBL] [Abstract][Full Text] [Related]
27. Expression and distribution of three transient receptor potential vanilloid(TRPV) channel proteins in human odontoblast-like cells.
Wen W; Que K; Zang C; Wen J; Sun G; Zhao Z; Li Y
J Mol Histol; 2017 Dec; 48(5-6):367-377. PubMed ID: 28905239
[TBL] [Abstract][Full Text] [Related]
28. Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells.
Liu Q; Wang X
Exp Ther Med; 2013 Nov; 6(5):1277-1282. PubMed ID: 24223658
[TBL] [Abstract][Full Text] [Related]
29. Involvement of Transient Receptor Potential Vanilloid Channel 2 in the Induction of Lubricin and Suppression of Ectopic Endochondral Ossification in Mouse Articular Cartilage.
Nakamoto H; Katanosaka Y; Chijimatsu R; Mori D; Xuan F; Yano F; Omata Y; Maenohara Y; Murahashi Y; Kawaguchi K; Yamagami R; Inui H; Taketomi S; Taniguchi Y; Kanagawa M; Naruse K; Tanaka S; Saito T
Arthritis Rheumatol; 2021 Aug; 73(8):1441-1450. PubMed ID: 33586252
[TBL] [Abstract][Full Text] [Related]
30. Novel role of TRPV2 in promoting the cytotoxicity of H2O2-mediated oxidative stress in human hepatoma cells.
Ma W; Li C; Yin S; Liu J; Gao C; Lin Z; Huang R; Huang J; Li Z
Free Radic Biol Med; 2015 Dec; 89():1003-13. PubMed ID: 26456053
[TBL] [Abstract][Full Text] [Related]
31. TRPV2-induced Ca
Bai H; Zhu H; Yan Q; Shen X; Lu X; Wang J; Li J; Chen L
Cell Commun Signal; 2018 Oct; 16(1):68. PubMed ID: 30326911
[TBL] [Abstract][Full Text] [Related]
32. Recurrent activations of transient receptor potential vanilloid-1 and vanilloid-4 promote cellular proliferation and migration in esophageal squamous cell carcinoma cells.
Huang R; Wang F; Yang Y; Ma W; Lin Z; Cheng N; Long Y; Deng S; Li Z
FEBS Open Bio; 2019 Feb; 9(2):206-225. PubMed ID: 30761248
[TBL] [Abstract][Full Text] [Related]
33. Functional TRPV2 and TRPV4 channels in human cardiac c-kit(+) progenitor cells.
Che H; Xiao GS; Sun HY; Wang Y; Li GR
J Cell Mol Med; 2016 Jun; 20(6):1118-27. PubMed ID: 26865051
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages.
Raudszus R; Paulig A; Urban N; Deckers A; Gräßle S; Vanderheiden S; Jung N; Bräse S; Schaefer M; Hill K
Br J Pharmacol; 2023 Nov; 180(21):2736-2749. PubMed ID: 37254803
[TBL] [Abstract][Full Text] [Related]
35. Structure-Based Discovery of a Subtype-Selective Inhibitor Targeting a Transient Receptor Potential Vanilloid Channel.
Chai H; Cheng X; Zhou B; Zhao L; Lin X; Huang D; Lu W; Lv H; Tang F; Zhang Q; Huang W; Li Y; Yang H
J Med Chem; 2019 Feb; 62(3):1373-1384. PubMed ID: 30620187
[TBL] [Abstract][Full Text] [Related]
36. Loratadine, an antihistaminic drug, suppresses the proliferation of endometrial stromal cells by inhibition of TRPV2.
Van den Eynde C; Held K; Ciprietti M; De Clercq K; Kerselaers S; Marchand A; Chaltin P; Voets T; Vriens J
Eur J Pharmacol; 2022 Aug; 928():175086. PubMed ID: 35714693
[TBL] [Abstract][Full Text] [Related]
37. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
Caprodossi S; Lucciarini R; Amantini C; Nabissi M; Canesin G; Ballarini P; Di Spilimbergo A; Cardarelli MA; Servi L; Mammana G; Santoni G
Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide attenuates microglia proliferation by sequentially facilitating calcium influx through TRPV2 channels, activating NFATC2, and increasing p21 transcription.
Maksoud MJE; Tellios V; Lu WY
Cell Cycle; 2021 Feb; 20(4):417-433. PubMed ID: 33530820
[TBL] [Abstract][Full Text] [Related]
39. Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy.
Iwata Y; Ohtake H; Suzuki O; Matsuda J; Komamura K; Wakabayashi S
Cardiovasc Res; 2013 Sep; 99(4):760-8. PubMed ID: 23786999
[TBL] [Abstract][Full Text] [Related]
40. Activation of TRPV2 negatively regulates the differentiation of mouse brown adipocytes.
Sun W; Uchida K; Takahashi N; Iwata Y; Wakabayashi S; Goto T; Kawada T; Tominaga M
Pflugers Arch; 2016 Sep; 468(9):1527-40. PubMed ID: 27318696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
